Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Deferred Revenue: 2010-2024

Historic Current Deferred Revenue for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to $4.3 million.

  • OptimizeRx's Current Deferred Revenue rose 822.3% to $25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.1 million, marking a year-over-year increase of 822.3%. This contributed to the annual value of $4.3 million for FY2024, which is 239302.33% up from last year.
  • Per OptimizeRx's latest filing, its Current Deferred Revenue stood at $4.3 million for FY2024, which was up 239302.33% from $172000.0 recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Current Deferred Revenue peaked at $4.3 million during FY2024, and registered a low of $164000.0 during FY2022.
  • In the last 5 years, OptimizeRx's Current Deferred Revenue had a median value of $285795.0 in 2020 and averaged $1.3 million.
  • As far as peak fluctuations go, OptimizeRx's Current Deferred Revenue tumbled by 8820.06% in 2022, and later skyrocketed by 239302.33% in 2024.
  • OptimizeRx's Current Deferred Revenue (Annual) stood at $285795.0 in 2020, then skyrocketed by 386.33% to $1.4 million in 2021, then crashed by 88.2% to $164000.0 in 2022, then rose by 4.88% to $172000.0 in 2023, then soared by 2393.02% to $4.3 million in 2024.
  • Its last three reported values are $4.3 million in FY2024, $172000.0 for FY2023, and $164000.0 during FY2022.